Inventor

RITTER KURT

US44 patents

⚠️ This page may combine multiple inventors who share the name “RITTER KURT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RITTER KURT

BASF AG

Dolastatin 15 derivatives

Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus

Peptides, the preparation and use thereof

1-amino-3-phenoxy propane derivatives as modulator agents and their applications

Preparation of active peptides

Compounds useful for the synthesis of dolastatin analogs

Compounds useful for the synthesis of dolastatin analogs

Active peptide and its preparation

Oligopeptides, the preparation and use thereof

Organic-chemical compound with ice-inhibitory action

Chiral compounds

BOEHME THOMAS

Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof

Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof

Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof

Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof

Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof

Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof

Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof

ABBOTT GMBH & CO KG

Pyrazolopyrimidines as therapeutic agents

Pyrazolopyrimidines as therapeutic agents

Antineoplastic peptides

Antineoplastic peptides

AVENTIS PHARMA SA

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors

Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors

SANOFI SA

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Substituted fused heterocycles as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

SANOFI AVENTIS DEUTSCHLAND

Azaindole-derivatives as factor Xa inhibitors

Indole derivatives as factor Xa inhibitors

Benzimidazole-derivatives as factor Xa inhibitors

ABBOTT LAB

Pyrazolopyrimidines as therapeutic agents

Method of identifying inhibitors of Lck

PLETTENBURG OLIVER

Isoquinoline derivatives

Isoquinoline derivatives

ABBOTT GMBH & CCO KG

Kinase inhibitors as therapeutic agents

AVENTIS PHARMA GMBH

Indole derivatives as factor Xa inhibitors

GENZYME CORP

Isoxazolidines as RIPK1 inhibitors and use thereof

AMBERG WILHELM

Antineoplastic peptides

SANOFI AVENTIS

Pyrazolopyridine derivatives as inhibitors of β-Adrenergic receptor kinase 1